Home
About Us
Resource Library
Site
Polio and prevention
Infected countries
Data and monitoring
Post-eradication
Research
Financing
Media room
You are here:
Research
>
Polio Pipeline
>
No.5 Winter 2010
OPV efficacy
OPV delivery
Affordable IPV
Vaccine-derived polioviruses
Frequently asked questions
Polio Pipeline
No.9
No.8 Summer 2011
No.7 Winter 2011
No.6 Summer 2010
No.5 Winter 2010
Polio Research
Conclusions and recommendations
Research area 1
Research area 2
Delivering monovalent OPV
Independent evaluation calls for more research to
Global status of licensure
The use of LQAS
Where are the immunity gaps?
No.4 Summer 2009
No.3 Winter 2009
No 2, Autumn 2008
No.1 Summer 2008
Polio Research Committee
Grants and collaboration
Antivirals
Winter 2010, no.5
Polio Research Committee outcomes, research priorities, evaluating SIAD, new monitoring mechanisms in Nigeria.
Download [pdf 136kb]
Articles
•
Polio research: helping reach more children and enhancing both the humoral and mucosal immunity
•
Conclusions and recommendations of the Polio Research Committee
•
Research area 1: understanding mucosal immunity in India
•
Research area 2: operational research to improve vaccination coverage and immunity
•
Delivering monovalent OPV to children in hard-to-reach communities using the Short Interval Additional Dose (SIAD) approach
•
Independent evaluation calls for more research to maximize impact of eradication strategies
•
Global status of licensure and pre-qualification processes for monovalent OPV type 1, 2 and 3 and bivalent OPV
•
The use of LQAS to assess polio immunization coverage in Nigeria
•
Where are the immunity gaps?
research
,
news
,
newsletter